The PE Ratio as of November 2024 (TTM) for Senti Biosciences, Inc. (SNTI) is -0.14

According to Senti Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.14. This represents a change of -35.48% compared to the average of -0.22 of the last 4 quarters.

Senti Biosciences, Inc. (SNTI) Historical PE Ratio (quarterly & annually)

How has SNTI PE Ratio performed in the past?

The mean historical PE Ratio of Senti Biosciences, Inc. over the last ten years is -18.95. The current -0.14 PE Ratio has changed -26.13% with respect to the historical average. Over the past ten years (40 quarters), SNTI's PE Ratio was at its highest in in the December 2023 quarter at 0. The PE Ratio was at its lowest in in the March 2021 quarter at -624078.29.

Senti Biosciences, Inc. (SNTI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Senti Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Senti Biosciences, Inc. (SNTI) Average PE Ratio

How has SNTI PE Ratio performed in the past?

The current PE Ratio of Senti Biosciences, Inc. (SNTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Senti Biosciences, Inc. (SNTI) PE Ratio vs. Peers

How is SNTI’s PE Ratio compared to its peers?

Senti Biosciences, Inc.’s PE Ratio is greater than ZIVO Bioscience, Inc. (-5.20), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.18), greater than Foghorn Therapeutics Inc. (-5.38), greater than Quoin Pharmaceuticals, Ltd. (-0.33), greater than SAB Biotherapeutics, Inc. (-0.64), less than Cingulate Inc. (-0.00), greater than Bellicum Pharmaceuticals, Inc. (-0.28), greater than Hillstream BioPharma, Inc. (-0.99), less than Lipella Pharmaceuticals Inc. (-0.00), greater than Fennec Pharmaceuticals Inc. (-120.74), greater than Monopar Therapeutics Inc. (-0.54), greater than Applied Molecular Transport Inc. (-0.43), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than SAB Biotherapeutics, Inc. (-0.64), less than Connect Biopharma Holdings Limited (7.24), greater than Tyra Biosciences, Inc. (-11.13), greater than RAPT Therapeutics, Inc. (-0.39), greater than Xilio Therapeutics, Inc. (-0.90), greater than Mineralys Therapeutics, Inc. (-4.06),

Build a custom stock screener for Senti Biosciences, Inc. (SNTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senti Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senti Biosciences, Inc. (SNTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senti Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.